Increased ET-1 and Reduced ET_B Receptor Expression in Uremic Hypertensive Rats

By D'Amours Martin   Chbinou Nadia   Beaudoin Jonathan   Lebel Marcel   Larivière Richard  

Clinical and Experimental Hypertension, Vol. 32, Iss. 1, 2010-02 ,pp. : 61-69

Informa Healthcare

Access to resources Recommend Favorite

TRANSCEND Aftermath: Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) at the Clinical Crossroad

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Angiogenesis and the ET-1/ET_A Receptor System: Immunohistochemical Expression Analysis in Bone Metastases from Patients with Different Primary Tumors

By Medinger M.   Adler C.P.   Schmidt-Gersbach C.   Soltau J.   Droll A.   Unger C.   Drevs J.  

Angiogenesis, Vol. 6, Iss. 3, 2003-01 ,pp. : 225-231

Springer Publishing Company

Access to resources Recommend Favorite

Is it Possible to Differentiate between Angiotensin II Type 1 (AT1) Receptor Blockers in Normotensive Volunteers?

By AZIZI M.   NICOLET L.   CHATELLIER G.   GUYENE T. T.   HEMPENIUS J.   MÉNARD J.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 53-53

Informa Healthcare

Access to resources Recommend Favorite

Release of Preformed Ang II from Myocytes Mediates Angiotensinogen and ET-1 Gene Overexpression In Vivo via AT1 Receptor

By Amedeo Modesti P.   Zecchi-Orlandini S.   Vanni S.   Polidori G.   Bertolozzi I.   Perna A.M.   Formigli L.   Cecioni I.   Coppo M.   Boddi M.   Serneri G.G.N.  

Journal of Molecular and Cellular Cardiology, Vol. 34, Iss. 11, 2002-11 ,pp. : 1491-1500

Academic Press

Access to resources Recommend Favorite